Medigus Ltd. (NASDAQ:MDGS) Stock Continues to Trend Lower: Now What?

October 25, 2021

Medigus Ltd. (NASDAQ: MDGS) is down 9% in a month. The company has announced that Eventer Technologies Ltd, its affiliate, has entered a memorandum of understanding with NFT tech firm Safee Cyber Technologies. Market Action: On Friday, MDGS stock lost 4.64% at $1.4400 with more than 228.12K shares, compared to its average volume of 607.97K shares. The stock has moved within a range of $1.4400 – 1.5399 after opening the…


Medigus Ltd. (NASDAQ:MDGS) Stock In Focus After The Recent Movement

September 21, 2021

Medigus Ltd. (NASDAQ:MDGS) jumped 7.5% after releasing its interim condensed consolidated financial results. This year ScoutCam made significant capital raising, with the last occurring on March 22, 2021. As a result, the company deconsolidated ScoutCam and diluted the holding to 27.76%. As of June 30, 2021, the company held 33.17% in Gix Internet Ltd, 35.86 in Polyrizon ltd, 50.03% in Jeff’s Brands Ltd, and 5.1% in Elbit Imaging Ltd.Since its…


Medigus Ltd (NASDAQ:MDGS) Stock Moves Up After Announcing New Acquisition

September 1, 2021

Israel based tech company Medigus Ltd (NASDAQ:MDGS) was in the news yesterday following a key announcement with regards to its affiliate Gix Internet. That led to a rally in the Medigus stock as well and it ended the day with gains of as much as 7%. The company announced that Gix Media, the subsidiary of its affiliate Gix Internet, inked a definitive agreement by way of which it is going…


Medigus Ltd (NASDAQ:MDGS) Stock is In News: Now What?

July 30, 2021

Technology firm engaged in advanced medical solutions, electric vehicles and charging solutions, Medigus Ltd (NASDAQ:MDGS) on July 30, 2021 announced privately held company engaged in biological gels, Polyrizon Ltd, owned partially by Medigus, showed pre-clinical data from its earlier announced pre-clinical study demonstrating potential to lower risk of coronavirus. The study was done in Israel for one month and tested various formulations of highly differential biological gel compared to controlled…